Several studies have reported an increase in opioid-induced mortality after the onset of COVID-19 in the United States (commencing in March 2020), largely ascribed to synthetic MOR-agonists such as fentanyl analogs (10, 23, 24). The gene discussed is OPRM1; the disease is COVID-19.